SLRN
Price
$2.60
Change
+$0.43 (+19.82%)
Updated
Feb 21 closing price
Capitalization
260.85M
32 days until earnings call
TRML
Price
$12.21
Change
-$0.16 (-1.29%)
Updated
Feb 21 closing price
Capitalization
313.1M
Ad is loading...

SLRN vs TRML

Header iconSLRN vs TRML Comparison
Open Charts SLRN vs TRMLBanner chart's image
ACELYRIN
Price$2.60
Change+$0.43 (+19.82%)
Volume$12.57M
Capitalization260.85M
Tourmaline Bio
Price$12.21
Change-$0.16 (-1.29%)
Volume$218.47K
Capitalization313.1M
SLRN vs TRML Comparison Chart
Loading...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLRN vs. TRML commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLRN is a Hold and TRML is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (SLRN: $2.60 vs. TRML: $12.21)
Brand notoriety: SLRN and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLRN: 543% vs. TRML: 78%
Market capitalization -- SLRN: $260.85M vs. TRML: $313.1M
SLRN [@Biotechnology] is valued at $260.85M. TRML’s [@Biotechnology] market capitalization is $313.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLRN’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • SLRN’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, SLRN is a better buy in the long-term than TRML.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLRN’s TA Score shows that 4 TA indicator(s) are bullish while TRML’s TA Score has 2 bullish TA indicator(s).

  • SLRN’s TA Score: 4 bullish, 5 bearish.
  • TRML’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, SLRN is a better buy in the short-term than TRML.

Price Growth

SLRN (@Biotechnology) experienced а +22.07% price change this week, while TRML (@Biotechnology) price change was -11.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

SLRN is expected to report earnings on Mar 27, 2025.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($313M) has a higher market cap than SLRN($261M). SLRN YTD gains are higher at: -17.197 vs. TRML (-39.793). TRML has higher annual earnings (EBITDA): -78.78M vs. SLRN (-324.52M). SLRN has more cash in the bank: 562M vs. TRML (282M). TRML has less debt than SLRN: TRML (290K) vs SLRN (6.56M). SLRN (0) and TRML (0) have equivalent revenues.
SLRNTRMLSLRN / TRML
Capitalization261M313M83%
EBITDA-324.52M-78.78M412%
Gain YTD-17.197-39.79343%
P/E RatioN/AN/A-
Revenue00-
Total Cash562M282M199%
Total Debt6.56M290K2,261%
TECHNICAL ANALYSIS
Technical Analysis
SLRNTRML
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TAGRX68.48N/A
N/A
JHancock Fundamental Large Cap Core A
SEQFX11.54N/A
N/A
SEI Emerging Markets Equity Y (SIT)
RRGRX7.23N/A
N/A
DWS RREEF Global Real Estate Secc R6
TSGMX15.59N/A
N/A
Transamerica Sustainable Growth Eq R6
QASGX25.23-0.91
-3.48%
Federated Hermes MDT Small Cap Growth A

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with CMND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
+19.82%
CMND - SLRN
38%
Loosely correlated
+0.78%
THAR - SLRN
36%
Loosely correlated
+1.99%
OLMA - SLRN
34%
Loosely correlated
-1.77%
TRML - SLRN
33%
Loosely correlated
-1.29%
SGMT - SLRN
33%
Poorly correlated
+2.36%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-1.29%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
42%
Loosely correlated
-5.84%
VYGR - TRML
37%
Loosely correlated
-0.94%
IPSC - TRML
35%
Loosely correlated
-2.51%
ARVN - TRML
35%
Loosely correlated
-3.27%
More